CSF biomarkers in PD (such as α-syn, Aβ42, tau, and NFL) have been suggested to possess the potential diagnostic and prognostic value of PD (Parnetti et al., 2019; Kwon et al., 2022). This evidence concerns the gene MAPT and Parkinson disease.